The University of Chicago Header Logo

Connection

Ravi Salgia to Randomized Controlled Trials as Topic

Back to Details
This is a "connection" page, showing publications Ravi Salgia has written about Randomized Controlled Trials as Topic.
Ravi Salgia
Connection Strength
0.461
Randomized Controlled Trials as Topic
  1. MET receptor in oncology: From biomarker to therapeutic target. Adv Cancer Res. 2020; 147:259-301.
    View in: PubMed
    Score: 0.139
  2. The promise of selective MET inhibitors in non-small cell lung cancer with MET exon 14 skipping. Cancer Treat Rev. 2020 Jul; 87:102022.
    View in: PubMed
    Score: 0.138
  3. Evidence-based role of bevacizumab in non-small cell lung cancer. Ann Oncol. 2013 Jan; 24(1):6-9.
    View in: PubMed
    Score: 0.083
  4. Durable complete response of metastatic gastric cancer with anti-Met therapy followed by resistance at recurrence. Cancer Discov. 2011 Dec; 1(7):573-9.
    View in: PubMed
    Score: 0.077
  5. Molecularly targeted therapies in non-small-cell lung cancer annual update 2014. J Thorac Oncol. 2015 Jan; 10(1 Suppl 1):S1-63.
    View in: PubMed
    Score: 0.024
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.